ADL Receives Certification from Quest Diagnostics

ADL has passed Quest Diagnostics certification for Bi-Directional HL7 Transmissions for Laboratory Orders and Results.

Now nursing homes using Quest Laboratories can submit Lab Orders and results the Results electronically. The system supports recurring orders and the results are returned in both PDF and data formats.

The Order Entry (ORM) HL7 message is a commonly used message type. ORM messages contain information about an order that includes placing new orders, canceling existing orders, discontinuation, holding, etc. Orders pertain to either materials (e.g., 1 liter of 0.9% saline) or services (e.g., a blood panel, etc.)

Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States including Puerto Rico. For more information:

//www.questdiagnostics.com/home/physicians/

Patient-Family Portal

ADL is releasing a Patient-Family Portal to provide residents and families with secured access to portions of a resident’s EMR (medical record). Each Resident receives an account that can be access by a Family or authorized representatives. Once logged in the user has easy and convenient access to the resident’s personal Dashboard that displays their Active health conditions orders, assessments and treatment plans.

The functions can be accessed remotely using a industry standard browser. to the resident’s dashboard. Provide this service without compromising access to the facility’s operational data.

Contact ADL for more information.

COVID-19 Medical Device Content

COVID-19 Medical Device Content

FDB has developed, at no cost or obligation, an extensive list of manufacturers and vendors of supplies such as ventilators, N95 masks, gloves, and other protective equipment. Part numbers and UDI information are included, as well as each manufacturer’s contact information. We hope that this information, curated from our FDB Prizm™ medical device knowledge platform and other available sources, will help organizations identify new suppliers for the items they are currently finding unavailable.

If hospitals and other healthcare organizations would like to receive this resource in easy-to-use spreadsheet form, they can complete and submit the contact form on our website at //www.fdbhealth.com/covid-19/covid-19-related-medical-device-information. FDB will be updating this information as new suppliers enter the market—including some non-traditional distributors that are jumping in to help meet the need—and will send these updates to everyone who receives the list.

FDB COVID-19 Drug Information

FDB has provided COVID-19 related drug information for three drugs: remdesivir, chloroquine, and hydroxychloroquine. This information includes professional content (specialty drug monographs) and consumer content (patient medication instructions from our Meducation® solution and consumer medication information from the FDB MedKnowledge® solution). Select COVID-19 testing kits have been added to the MedKnowledge database as well. This content is available for anyone to view and download, at no cost or obligation, at //fdbhealth.com/covid-19/covid-19-related-drug-information.

We hope you find it helpful.